|
|
 |
Charles
J. Arntzen
Dr.
Arntzen is internationally recognized for his work on the development
of transgenic plants to yield oral vaccines to meet the needs of
developing nations where infectious diseases are a major cause of
infant mortality. Professor Arntzen is the Florence Ely Nelson Presidential
Chair in Plant Biology, Arizona State University, Tempe, Arizona
and Founding Director of the ASU Biomedical Institute. He also serves
as President/CEO Emeritus of the Boyce Thompson Institute for Plant
Research, Inc., a not-for-profit corporation affiliated with Cornell
University. Dr. Arntzen was elected to the U.S. National Academy
of Sciences in 1983, and to the National Academy of India in 1984
in recognition of his collaborative international research in that
country. In 1984 he joined the DuPont Company in Wilmington, Delaware,
and later became the company's Director of Biotechnology in the
Agricultural Products Department. In 1988 he was appointed Dean
and Deputy Chancellor for Agriculture of Texas A&M University,
and subsequently served as Director of the university's Plant Biotechnology
Program of the Institute of Biosciences and Technology. Dr. Arntzen
has played a major role in many national and international scientific
activities, including service for eight years on the editorial board
of SCIENCE, as Chairman of the National Institutes of Health Biotechnology
Policy Board, and as Chair of the Biobased Industrial Products Committee
for the National Academy of Sciences. Dr. Arntzen served until 1998
on the Board of Directors of DeKalb Genetics, Inc. and is currently
on the Board of Directors of Third Wave Agbio, Inc.; on the Advisory
Board of the Burrill and Company's Agbio Capital Fund and The Nutraceuticals
Fund; and on Scientific Advisory Boards for Sumitomo Chemical Company,
Ltd., Phytera, Inc., and Valigen, Inc. He also serves as a Distinguished
Advisor on the Council for Biotechnology.
Back
to top ^
|
|
|
Roger
Clemens
One
of the world's leading experts in human nutrition, Dr. Clemens recently
joined the USC School of Pharmacy after serving as the Scientific
Advisor for Nestlé USA for more than 20 years. Dr. Clemens
received a Master of Public Health in Nutrition in 1973 from UCLA,
and his Doctor of Public Health in Nutrition and Biological Chemistry,
also from UCLA. Dr. Clemens spent much of his career in industry
working as Scientific Advisor for Carnation/Nestlé USA from
1978-1999. Throughout his career he has held adjunct professor appointments
at many universities, including UCLA (Nutritional Sciences), California
State University Long Beach (Human Nutrition), California Polytechnic
State University (Professor, Department Head, Food Science and Nutrition),
and California State Polytechnic University Pamona (Professor, Food
Science and Nutrition). He has published more than 30 original manuscripts
and participated in more than 70 invited lectures on the topics
of food science and nutrition. Dr. Clemens has served as an expert
panel member for the Food and Drug Administration, International
Food Information Council, California Dairy Council, and the Life
Sciences Research Organization. Dr. Clemens is a professional member
of the Institute of Food Technologists and a leader in this society
at local (Chair, Southern California IFT) and national levels (Chair,
Toxicology and Safety Evaluation Division and Nutrition Division).
He is also a member of the American Institute of Nutrition and a
Fellow of the American College of Nutrition. Dr. Clemens has received
many awards and honors for his leadership, including SCIFTS Distinguished
Service Award (1999), Phi Tau Sigma Award (Honor Society for Food
Scientists, 1997), Fellowship in the Marilyn Magaram Center for
Food Science, Nutrition and Dietetics (1993), Fellowship in the
American College of Nutrition (1992), University Service Award,
California State University (1990), and the Meritorious Service
Award of the California Dietetic Association (1987). He is also
on the Advisory and Development Council for several universities
including California State University (Long Beach), Loma Linda University,
California State Polytechnic University (Pamona), and California
Polytechnic State University (San Luis Obispo).
Back
to top ^
|
|
|
Colin
Ratledge
Professor
Ratledge is one of the world's leading experts on the production
of single cell oils; particularly the production of polyunsaturated
fats by yeast, fungi and algae. Professor Ratledge has conducted
extensive research in the biochemistry of the formation of arachidonic
acid and related polyunsaturated fatty acids by Mortierella fungi
(supported by BBSRC), as well as the formation of docosahexaenoic
acid and related polyunsaturated fatty acids by the marine algae
Crypthecodinium cohnii (supported by EU). He has also worked extensively
on the genetic control of key genes involved in lipid accumulation
and the biochemistry and regulation of acetyl-CoA in microorganisms.
From 1964-1967 he was a research scientist at Unilever Research
Laboratory, and since 1967 has been on staff at the University of
Hull, where he has been professor and head of the Biochemistry Department.
He is a Fellow of the Royal Society of Chemistry, and a Fellow of
the Institute of Biology. Professor Ratledge has published more
than 180 peer-reviewed research papers, edited or co-edited 16 books,
and written more than 80 review articles. He is a member of the
editorial board for Enzyme and Microbial Technology, Biometals,
Lipid Technology, and Lipid Technology Newsletter. He is Associate
editor of Lipids, as well as Editor in Chief of World Journal of
Microbiology and Biotechnology, in addition to Biotechnology Letters.
He has been a member of the Science Advisory Committee of the European
Federation of Biotechnology (1983-87), Vice Chairman of the British
Coordinating Committee for Biotechnology (1986-91, including Chairman
1989-91), and a member of the Management Committee of the Advanced
Centre for Biochemical Engineering, University College London (1996
to present). Professor Ratledge holds a Ph.D. in Biochemistry from
Manchester University's College of Science and Technology.
Back
to top ^
|
|
|
Oskar
Zaborsky
Dr.
Zaborsky brings many years of experience in working with governments,
academic institutions and industry in the United States and worldwide,
and has an extensive publication list in the field of marine biotechnology.
He received his Ph.D. in Chemistry at the University of Chicago
in 1964 and is presently the Director of Advanced Technology of
the Oceanic Institute (Waimanalo, HI). He is also the founder and
President of OXCOM International Inc., a consulting firm specializing
in biotechnology. From 1995 to 1999 he worked at the University
of Hawaii as a Visiting Scholar from the University of California,
Berkeley (Department of Chemical Engineering). During this time
he founded and established the National Science Foundation's Marine
Biotechnical Engineering Center (MarBEC) and brought in over $14
million in extramural funding. In 1994, Dr. Zaborsky founded the
McLean, VA-based Institute for BioEnvironmental Information and
Studies, which, among other projects, formulated a strategic plan
for the University of Maryland Biotechnology Institute on environmental
studies, and assisted in the formulation of a Center on Environmental
Diagnostics. From 1993-1995, Dr. Zaborsky was a Faculty Associate
of Johns Hopkins University, served as Director of Science and Technology
for the National Environmental Policy Institute (NEPI), and served
as the Biotechnology Program Advisor at the Argonne National Laboratory.
While at Argonne, he formulated and successfully executed the largest
DOC-NIST-ATP project on biocatalysis ($15.6 million) involving Eastman
Chemical Company, Genecor International Inc., Argonne National Laboratory,
and two small business firms. From 1989 to 1992, Dr. Zaborsky was
a Director on the Board on Biology of the Commission on Life Sciences
of the National Academy of Science's National Research Council (NRC).
At the NRC, he was involved in planning and conducting technical
and policy studies in biology and biotechnology, including studies
on bioprocess engineering, marine biotechnology, and bio-based industrial
products. Dr. Zaborsky is the founding editor of several journals,
including Enzyme and Microbial Technology and Biotechnology Patent
Digest (Bioinvention). He was a member of the U.S. Army Research
Laboratory Panel on Biotechnology, Advisory Committee of the DoD
Army CB Research & Technology Directorate, and WTEC (NSF-DARPA-DOC)
Panel on Japan's Key Technology Center Program.
Back
to top ^
|
|
|
Yonathan
Zohar
A
world-respected expert in marine biotechnology, Dr. Zohar is a Professor
and Director of the Center of Marine Biotechnology (COMB) at the
University of Maryland Biotechnology Institute (UMBI) in Baltimore,
MD. With a specialty in fish reproduction, he laid the fundamental
groundwork for the understanding of why farm-raised fish did not
reproduce predictably in captivity. This led to the discovery of
new forms of gonadotropin-releasing hormone (GnRH) and ultimately
to the development of a GnRH-based therapy to induce farmed fish
to spawn in captivity. He has cloned the cDNA and genes coding for
three GnRHs from striped bass and seabream, and is presently studying
the expression patterns of these genes. These successes have led
to new areas of research, including the development of delivery
systems for controlled and efficient administration of hormones
and vaccines to fish being raised for aquaculture. He received his
Ph.D. in Endocrinology at the University of Pierre and Marie Curie
in Paris in 1982. A pivotal figure in current aquaculture research,
Professor Zohar is an enthusiastic and effective speaker about the
field of marine biotechnology, and has encouraged and trained many
new scientists in this area.
Back
to top ^
|
|
